Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.66p
   
  • Change Today:
      0.060p
  • 52 Week High: 5.90
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 2,810,802
  • Market Cap: £13.27m
  • RiskGrade: 328
  • Beta: 0.05

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £39,519
Lisa Baderoon 583,963 £15,504
Tim Franklin 525,000 £13,939

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 64,932,129 £1,723,948
Luca & Associates AG 22,000,000 £584,100
Invesco Ltd 17,872,341 £474,511
Aviva Investors Global 11,285,180 £299,622
Alora Pharmaceuticals LLC 10,909,091 £289,636
M&G Investments 7,600,000 £201,780
Prudential plc 7,600,000 £201,780
Capital Income Builder 4,870,367 £129,308
Dr R Zimmer 4,551,553 £120,844
Odey Asset Management 3,433,319 £91,155
Rhone Trustees (Switzerland) SA 3,386,000 £89,898
Pictet Overseas Trust Corporation Limited 3,287,500 £87,283

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.66p
Change Today 0.060p
% Change 2.31 %
52 Week High 5.90
52 Week Low 1.09
Volume 2,810,802
Shares Issued 499.72m
Market Cap £13.27m
Beta 0.05
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.84% below the market average28.84% below the market average28.84% below the market average28.84% below the market average28.84% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Price Trend
64.17% above the market average64.17% above the market average64.17% above the market average64.17% above the market average64.17% above the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
16:26 6,102 @ 2.61p
16:14 100,000 @ 2.73p
16:13 100,000 @ 2.72p
16:10 100,000 @ 2.60p
16:08 75,000 @ 2.73p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page